Preventing youth violence through hospital-based interventions
Official title: Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
Run by Virginia Commonwealth University · NCT05078164 · Data updated 2026-11-12
This study is testing a hospital program called Bridging the Gap to see if it can help reduce violence among young people aged 10-17 who have been hurt in violent incidents.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 17 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 1 site (Richmond, Virginia) |
| Status | Recruiting |
| Started | May 4, 2022 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | February 4, 2026 |
| Trial ID | NCT05078164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are youth aged 10-17 who are receiving treatment for a violence-related injury and their adult caregivers.
✕Probably not a fit
Patients younger than 10 years or older than 18 years, as well as prisoners, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of a hospital-based violence intervention called Bridging the Gap for reducing youth violence among adolescents who have experienced violent injuries. Approximately 600 participants, including youth aged 10-17 and their adult caregivers, will be randomized into two groups: one receiving the Bridging the Gap intervention and the other receiving standard treatment. The intervention includes in-hospital support and three months of community case management services. Researchers will assess the impact of the intervention on various behaviors, including firearm use and aggression, over a period of up to six months.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce youth violence and improve overall safety for adolescents.
How similar studies have gone: Other studies have shown promise in using hospital-based interventions to reduce violence, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Youth are aged 10-17 years and their adult caregivers are aged 18 years and older 2. Receiving treatment in the hospital for a violence-related injury (e.g., gunshot wound) or referred to BTG/IVPP services 3. English speaking 4. Eligible for BTG services (which includes living within the BTG catchment area for the hospital; Richmond City and neighboring counties) Exclusion Criteria: 1. Youth are \< 10 years old 2. Youth are \> 18 years old 3. Prisoners
Where it's running
-
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting
Study contacts
- Principal investigator: Nicholas Thomson — Virginia Commonwealth University
- Study coordinator: Nicholas Thomson
- Email: Nicholas.Thomson@vcuhealth.org
- Phone: 804-628-5541
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how ADT for prostate cancer may raise blood pressure and whether nerves or kidneys are involved
This study tests whether nervous system or kidney dysfunction contributes to high blood pressure in men receiving androgen deprivation therapy for prostate cancer.
-
Role of Visual Attention and Environment on Real-World Walking for People With Lower Limb Amputation
This study tests how vision-based thinking and different walking environments affect real-world gait in people with a leg amputation.
-
HD-tDCS during CBT for Cocaine Use Disorder
This study tests whether adding high-definition transcranial direct current stimulation to cognitive behavioral therapy helps adults with cocaine use disorder see if CBT works better.
-
Metronomic Decitabine-Cedazuridine and Venetoclax therapy for relapsed/refractory AML and high-risk blood cancers
This phase 2 trial tests a metronomic decitabine-cedazuridine plus venetoclax regimen versus azacitidine plus venetoclax in adults with relapsed/refractory AML or high-risk MDS/MPN.
-
Impact of Food Help on Adherence to Cancer Treatment
This study tests whether providing food assistance helps adults with cancer who have food insecurity stick to their treatment plans.
-
Understanding long-term progression in myotonic dystrophy type 1 (DM1)
This study will follow adults with DM1 for at least four years to see how walking, hand function, muscle strength, heart rhythms, and lung function change over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.